We also evaluated the clinical parameters of kidney disease in mice stimulated in vivo with imiquimod (a TLR7 agonist as a surrogate for viral exposure) and ODN 2395 (a TLR9 agonist, as a surrogate for bacterial exposure). Here, TLR7 is linked to kidney disorder.